Should testing of donors be restricted to active Zika virus areas?

The Lancet Infectious Diseases

Volumn 16, Issue 10, 2016, Pages 1108-1109

  Musso, Didier ^a   Baud, David ^b,c   Freedman, David O ^d  

^a INSTITUT LOUIS MALARDÉ   (French Polynesia)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONOR SELECTION; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; SPERM DONOR; VIRUS TRANSMISSION; ZIKA FEVER; ZIKA VIRUS;

EID: 84990045092     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30337-1     Document Type: Letter

References (5)

1. 1 Mansuy, JM, Pasquier, C, Daudin, M, et al. Zika virus in semen of a patient returning from a non-epidemic area. Lancet Infect Dis 16 (2016), 894–895.
2. 2 WHO. Situation report: Zika virus microcephaly Guillain-Barré syndrome. July 7, 2016, 2016, World Health Organization, Geneva.
3. 3 Rafiei, N, Hajkowicz, K, Redmond, A, et al. First report of Zika virus infection in a returned traveller from the Solomon Islands. Med J Aust, 204, 2016, 186 e1.
4. 4 Meltzer, E, Lustig, Y, Leshem, E, et al. Zika virus disease in traveler returning from Vietnam to Israel. Emerg Infect Dis 22 (2016), 1521–1522.
5. 5 Musso, D, Gubler, DJ, Zika virus. Clin Microbiol Rev 29 (2016), 487–524.